MERC 241220 15.00C (MERC241220C15000) Stock Options, News & Quotes

0.23
0.000.00%

15min DelayTrading Jul 23 11:54 ET

0.00High0.00Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Jaguar8

Oct 16 18:51

NEWS

$Mercer International (MERC.US)$
Mercer International Inc. Announces Preliminary Results for the Third Quarter of 2024 and Earnings Conference Call Details
Mercer International Inc. (Nasdaq: MERC) reported preliminary financial results for Q3 2024. Key highlights include:
- Revenues: $502.1 million
- Operating income: $8.8 million
- Operating EBITDA: $50.5 million
- Net loss: $17.6 million
- Liquidity: ~$554 million
The company faced unscheduled downtime at its mills, impacting pulp productio...

Moomoo AI

Mar 6 07:21

Mercer's acquisition of MDK is a strategic move to bolster its services for ultrahigh-net-worth clients, a rapidly expanding segment. The deal also aims to broaden Mercer's footprint in the Pacific Northwest market.

Mercer Makes Ultrahigh-Net-Worth Play With Acquisition of $2.5 Billion Seattle Firm -- Barrons.com

Moomoo AI

Dec 6, 2023 08:49

The fall in revenue and lack of profitability for Mercer International contribute to a pessimistic market viewpoint. However, the company's substantial dividend payments paint a more comprehensive picture, when considering total shareholder return.

Shareholders in Mercer International (NASDAQ:MERC) Have Lost 33%, as Stock Drops 8.1% This Past Week

Analysts Notebook

Jul 6, 2022 07:10

Columns Top upgrades and downgrades on 7/6: MRK, EOG, ABT, UNP and more

Upgrades
• $A.O. Smith (AOS.US)$ : Longbow Research Upgrades to Buy from Neutral - PT $71
• $Callon Petroleum (CPE.US)$ : RBC Upgrades to Outperform from Sector Perform - PT $75
• $Dun & Bradstreet (DNB.US)$ : BofA Securities Upgrades to Neutral from Underperform - PT $17 (from $16)
• $Enanta Pharmaceuticals (ENTA.US)$ : Evercore ISI Upgrades to Outperform from In Line - PT $62 (from $39)
• $Corning (GLW.US)$ : CFRA Upgrades to Strong Buy ...

Hucktosoar

Jan 7, 2022 05:08

$Mercer International (MERC.US)$ The head of India's leading medical research institute said on Wednesday that Mercer's new oral crown drug molnupiravir has "significant safety issues" that may prevent it from joining the country's list of viral treatments.
The oral drug, molnupiravir, is said to ultimately stop the replication of the virus by introducing a different mechanism in the genetic material, but it could affect growing human cells.